FDA Adverse Event Malfunction Summary report: N

TR BAND

MDR report key: 1915706 · Received November 19, 2010

Report

Report Number
9681834-2010-00035
Event Type
Malfunction
Date Received
November 19, 2010
Date of Event
October 22, 2010
Report Date
October 22, 2010
Manufacturer
TERUMO CORPORATION, ASHITAKA
Product Code
DXC
PMA / PMN Number
K070423
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

(B)(4): ALTHOUGH THERE WAS REPORTEDLY NO IMPACT TO THE PT, THE EVENT DESCRIPTION INDICATES THAT APPROXIMATELY 180-CC OR MORE OF BLOOD LOSS DID OCCUR. RESULTS: ARE BASED ON EVAL OF USER FACILITY INFO ONLY; AND BASED UPON EVAL OF THE RETAINED SAMPLE. CONCLUSION: BASED UPON EVAL OF USER FACILITY INFO ONLY; AND BASED UPON EVAL OF THE RETAINED SAMPLE. THE INVOLVED DEVICE IS NOT AVAILABLE TO BE RETURNED FROM THE USER FACILITY FOR EVAL. EVAL OF THE RETAINED SAMPLE CONFIRMED THERE WERE NO DEFECTS OR ANOMALIES. A REVIEW OF THE DEVICE HISTORY RECORDS CONFIRMED THAT THERE WERE NO PRODUCTION RELATED PROBLEMS FOR THIS LOT NUMBER. A REVIEW OF THE COMPLAINT FILES CONFIRMED THAT THIS LOT NUMBER HAS NOT BEEN REPORTED PREVIOUSLY. THE CAUSE FOR THE REPORTED DEFLATION OF THE TR BAND CANNOT BE DETERMINED BASED UPON THE AVAILABLE INFO. THE LABELING DOES ADDRESS THE POTENTIAL FOR SUCH AN EVENT IN THE INSTRUCTIONS-FOR-USE WITH STATEMENTS SUCH AS: "DO NOT INJECT MORE THAN 18ML OF AIR. THERE IS A POSSIBILITY OF DAMAGING THE DEVICE IF THIS VOLUME IS EXCEEDED;" "PT SHOULD NOT BE LEFT UNATTENDED WHILE THE TR BAND IS IN USE;" AND "DEPENDING ON THE PT'S CONDITION AND THE DEGREE OF BALLOON PRESSURE, AN ADVERSE EVENT INCLUDING ARTERY OCCLUSION, HYPODERMIC HEMATOMA, HEMORRHAGE, PAIN, OR NUMBNESS MAY OCCUR. CHECK THE PROGRESS OF THE HEMOSTASIS AND ADJUST THE AIR PRESSURE ACCORDINGLY;" AND "WHILE USING, BE CAREFUL NOT TO PUT EXCESSIVE LOAD ON THE PRESSURE CONFIRMATION BALLOON OR COMPRESSION BALLOON THAT COULD BREAK IT." ALL CURRENTLY AVAILABLE INFO HAS BEEN PLACED ON FILE BY QA AT THE MANUFACTURING FACILITY FOR APPROPRIATE TRACKING, TRENDING AND FOLLOW-UP. (B)(4).

Description of Event or Problem · 1

THE USER FACILITY REPORTED THAT THE TR BAND "BURST" DURING USE. THE FOLLOWING INFO WAS PROVIDED BY THE USER FACILITY: THE PHYSICIAN APPLIED THE TR BAND; THE 15 MINUTE CHECKS WERE COMPLETED WITH NO PROBLEM; THE BAND APPARENTLY DEFLATED AT SOME POINT BEFORE THE FIRST 1-HOUR CHECK; THE PT WAS FOUND TO HAVE BLED APPROXIMATELY 180-CC OR MORE OF BLOOD WITH CLOTS WAS NOTED ON THE BED; TRANSFUSION WAS NOT REQUIRED; THE PT IS REPORTED TO BE "DOING WELL."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TR BAND DXC TERUMO CORPORATION, ASHITAKA NA 100721

Patients

Seq Age Sex Outcome Treatment
1 UNK